Phreesia Cash on Hand 2019-2024 | PHR
Phreesia cash on hand from 2019 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Phreesia Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $88 |
| 2023 | $177 |
| 2022 | $314 |
| 2021 | $219 |
| 2020 | $90 |
| 2019 | $2 |
| 2018 | $ |
| Phreesia Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-01-31 | $88 |
| 2023-10-31 | $103 |
| 2023-07-31 | $128 |
| 2023-04-30 | $150 |
| 2023-01-31 | $177 |
| 2022-10-31 | $210 |
| 2022-07-31 | $241 |
| 2022-04-30 | $269 |
| 2022-01-31 | $314 |
| 2021-10-31 | $400 |
| 2021-07-31 | $440 |
| 2021-04-30 | $451 |
| 2021-01-31 | $219 |
| 2020-10-31 | $254 |
| 2020-07-31 | $84 |
| 2020-04-30 | $90 |
| 2020-01-31 | $90 |
| 2019-10-31 | $91 |
| 2019-07-31 | $100 |
| 2019-04-30 | |
| 2019-01-31 | |
| 2018-10-31 | |
| 2018-07-31 | |
| 2018-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.379B | $0.356B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.115B | 20.38 |
| Inspire Medical Systems (INSP) | United States | $4.725B | 0.00 |
| Axonics (AXNX) | United States | $3.452B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.070B | 0.00 |
| 10x Genomics (TXG) | United States | $3.049B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.016B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.978B | 0.00 |
| Enovis (ENOV) | United States | $2.863B | 21.22 |
| Azenta (AZTA) | United States | $2.768B | 155.58 |
| Privia Health (PRVA) | United States | $2.028B | 113.33 |
| Schrodinger (SDGR) | United States | $1.664B | 0.00 |
| Omnicell (OMCL) | United States | $1.454B | 50.25 |
| Standard BioTools (LAB) | United States | $0.725B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.673B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.649B | 0.00 |
| Talkspace (TALK) | United States | $0.475B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.464B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.415B | 0.00 |
| Pulmonx (LUNG) | United States | $0.351B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.301B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.213B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.190B | 0.00 |
| Outset Medical (OM) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.144B | 0.00 |
| TruBridge (TBRG) | United States | $0.139B | 7.46 |
| 111 (YI) | China | $0.112B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.111B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.068B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.067B | 0.00 |
| Augmedix (AUGX) | United States | $0.060B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.043B | 0.00 |
| CareCloud (CCLD) | United States | $0.040B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Cue Health (HLTH) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Syra Health (SYRA) | United States | $0.011B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |